Andrew R. Crescenzo
CIK 1363902 · Chief Financial Officer · last filed 2025-08-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.4K
Companies
2
Total Filings
15
Lifetime Open-Market Net
$279.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STSSW | Chief Financial Officer | 40,000 | $0.03 | $1.4K | $279.2K | 7 | 2025-08-26 |
| ENZO BIOCHEM INC (ENZ) Delisted | Senior VP of Finance | 52,452 | $0.31 | $16.5K | $0 | 8 | 2014-01-22 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-30 | ENZO BIOCHEM INC (ENZ) Delisted | Grant (A) | +12,000 | $0 | EDGAR |
| 2011-06-06 | ENZO BIOCHEM INC (ENZ) Delisted | Grant (A) | +12,000 | $0 | EDGAR |
| 2010-02-02 | ENZO BIOCHEM INC (ENZ) Delisted | Grant (A) | +12,000 | $0 | EDGAR |
| 2009-01-26 | ENZO BIOCHEM INC (ENZ) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
| 2007-12-12 | ENZO BIOCHEM INC (ENZ) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.